openPR Logo
Press release

CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications

05-21-2024 07:08 PM CET | Health & Medicine

Press release from: ABNewswire

CD Bioparticles Introduces Functional Agarose Particles

CD Bioparticles proudly announces the launch of its new Functional Agarose Particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles [https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html] designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic acid isolation.

CD Bioparticles offers a range of functional agarose particles that can be used to covalently capture tagged biomolecules, such as tagged proteins, or to immobilize proteins and antibodies. They can also serve as hydrophobic chromatographic separation media, immobilized metal ion affinity chromatography resins, ion exchange chromatography resins, etc., which are suitable for conjugation of antibodies, streptavidin, enzymes and nucleic acids to activated agarose particles. They also play a critical role in the production of recombinant proteins and the purification of monoclonal antibodies. They are an important carrier tool in molecular biology and medical research, and their importance extends to biopharmaceutical and industrial engineering applications.

The new functional agarose particles are available with a variety of functional groups, including hydrophobic, ion exchange, and affinity chromatography groups. This allows researchers to choose the particles that best suit their specific needs. For example, the hydrophobic interaction chromatography (HIC) separation particles (functionalized with butyl, phenyl, octyl) can be utilized to separate proteins based on their hydrophobicity, while the immobilized metal affinity chromatography (IMAC) particles (functionalized with Al-NTA, Co2+, Co-IDA, Co-NTA, Cu-NTA, Fe-NTA, IDA, Ni2+, Ni-IDA, etc.) can be used to purify and enrich proteins such as His-tagged proteins.

In addition, agarose particles functionalized with DEAE, sulfopropyl, carboxymethyl, quaternary ammonium can be used as IEC resins with high ion exchange capacity and less nonspecific adsorption, which can be applied in the laboratory preparation of biomolecules such as proteins, nucleic acids and peptides. Activated agarose particles (functionalized with azide, alkyne, methyltetrazine, TCO, disulfide, etc.) can also be used for coupling of biomolecules.

The new functional agarose particles are available in a variety of sizes, ranging from 25 m to 400 m. In addition to their wide range of functionalities and sizes, these functional agarose particles offer a unique combination of properties that make them ideal for a broad range of applications, including excellent chemical stability, high yield and customizability. These particles can selectively bind to specific biomolecules, and this targeted binding capability streamlines the purification process, reducing time and effort for researchers.

CD Bioparticles' Functional Agarose Particles are available in a variety of configurations to meet the specific needs of each research project. These particles offer superior efficiency and selectivity, enabling researchers to achieve faster and more accurate results. The company also offers custom bead development services to create particles tailored to unique applications. For more information, please visit https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-introduces-functional-agarose-particles-for-biomedical-research-applications]
State: New York
Country: United States
Website: https://www.cd-bioparticles.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications here

News-ID: 3506681 • Views:

More Releases from ABNewswire

Shoulder Replacement Market Poised for Transformative Growth by 2030: Market Drivers, Opportunities | DelveInsight
Shoulder Replacement Market Poised for Transformative Growth by 2030: Market Dri …
The shoulder replacement devices market is experiencing robust growth, fueled by an aging population, increasing prevalence of shoulder disorders, technological advancements by leading shoulder prosthesis manufacturers, including Zimmer Biomet, Johnson & Johnson, Wright Medical Group (acquired by Stryker), Scripps Health, Smith & Nephew, and Arthrex in implant design, and growing adoption of reverse shoulder arthroplasty procedures. DelveInsight's "Shoulder Replacement Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2030
Inflammatory Breast Cancer Market Expected to Experience Substantial Growth by 2034: Market Opportunities, FDA Approvals | DelveInsight
Inflammatory Breast Cancer Market Expected to Experience Substantial Growth by 2 …
The inflammatory breast cancer market is poised for significant growth with a promising pipeline of emerging therapies targeting this rare but aggressive disease. Key breast cancer companies, including Merck, AstraZeneca, Gilead Sciences, Daiichi Sankyo, Pfizer, and several others, are actively developing innovative treatments to address the high unmet needs in inflammatory breast cancer management. DelveInsight's "Inflammatory Breast Cancer - Market Insight, Epidemiology And Market Forecast [https://www.delveinsight.com/report-store/inflammatory-breast-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report provides an in-depth understanding
Bone Resorption Market Expected to Grow Significantly by 2032: Market Opportunities, Strategic Investments, FDA Approvals | DelveInsight
Bone Resorption Market Expected to Grow Significantly by 2032: Market Opportunit …
The bone resorption market is poised for substantial transformation, driven by the rising prevalence of osteoporosis and related disorders, an aging population, and significant advancements in targeted therapies. Key bone resorption companies, including Bioventus, Isto Biologics, Locate Bio, Kuros Biosciences, OssDsign, BONESUPPORT, Cerapedics, DiscGenics, Osteopore, TherageniX, Stryker, DePuy Synthes, Medtronic, Zimmer Biomet, and Orthofix, among others, are innovating in this landscape. DelveInsight's "Bone Resorption - Market Insight, Epidemiology and Market Forecast
Metastatic HR+/HER2- Breast Cancer Market Projected to Expand Significantly by 2034: Market Opportunities, FDA Approvals and Emerging Targeted Therapies | DelveInsight
Metastatic HR+/HER2- Breast Cancer Market Projected to Expand Significantly by 2 …
The metastatic HR+/HER2- breast cancer market is experiencing robust growth, fueled by an increasing patient pool and the introduction of innovative targeted therapies. Key breast cancer companies, such as Pfizer, Novartis, AstraZeneca, Roche, Arvinas, Olema Pharmaceuticals, Eli Lilly, and others, are shaping the treatment landscape for this most prevalent subtype of breast cancer. DelveInsight's "Metastatic HR+/HER2- Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034 [https://www.delveinsight.com/report-store/hr-positive-her2-negative-breast-cancer-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report provides comprehensive insights into the

All 5 Releases


More Releases for Bioparticles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported. Flow cytometry is a convenient detection
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability. The polystyrene family, a group of polymers derived from
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents. CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings. With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the
CD Bioparticles Releases Chitosans for Research Use
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies. These new chitosans and derivatives are with various water solubility, and scientists now are accessible to products like CInd™ analogous hyaluronic acid chitosan, CInd™ carboxymethyl chitosan, CInd™ chitosan azelate and glycol chitin. One new product in this new release is the CInd™